A. Burchard

418 total citations
9 papers, 317 citations indexed

About

A. Burchard is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, A. Burchard has authored 9 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Hepatology. Recurrent topics in A. Burchard's work include Cardiac Arrhythmias and Treatments (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Mast cells and histamine (1 paper). A. Burchard is often cited by papers focused on Cardiac Arrhythmias and Treatments (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Mast cells and histamine (1 paper). A. Burchard collaborates with scholars based in Germany, United States and Austria. A. Burchard's co-authors include Roland Richard Tilz, Feifan Ouyang, Erik Wißner, Karl‐Heinz Kück, Andreas Metzner, Andreas Rillig, Shibu Mathew, K. R. Julian Chun, Dieter Nuyens and Andreas Metzner and has published in prestigious journals such as Journal of Hepatology, Physiology & Behavior and Heart Rhythm.

In The Last Decade

A. Burchard

9 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Burchard Germany	7	286	41	18	16	14	9	317
Lai Chow Kok United States	6	372 1.3×	35 0.9×	10 0.6×	30 1.9×	13 0.9×	11	382
Boris Schmidt Germany	5	387 1.4×	59 1.4×	13 0.7×	22 1.4×	15 1.1×	7	403
Kazuya Yamao Japan	11	391 1.4×	33 0.8×	13 0.7×	15 0.9×	19 1.4×	37	407
Noboru Ichihara Japan	13	370 1.3×	48 1.2×	4 0.2×	16 1.0×	27 1.9×	27	387
E. Jessurun Netherlands	6	371 1.3×	30 0.7×	9 0.5×	21 1.3×	31 2.2×	11	382
JOCHEN SCHIEBELING‐RÖMER Germany	6	408 1.4×	57 1.4×	18 1.0×	46 2.9×	29 2.1×	8	420
Peter Rausch Germany	13	761 2.7×	96 2.3×	41 2.3×	22 1.4×	26 1.9×	17	780
Subramanya K. Prasad United States	6	410 1.4×	38 0.9×	55 3.1×	35 2.2×	37 2.6×	11	449
P. Janse Netherlands	10	541 1.9×	42 1.0×	11 0.6×	19 1.2×	46 3.3×	17	559
Shigeki Kusa Japan	19	768 2.7×	59 1.4×	21 1.2×	25 1.6×	34 2.4×	57	791

Countries citing papers authored by A. Burchard

Since Specialization

Citations

This map shows the geographic impact of A. Burchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Burchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Burchard more than expected).

Fields of papers citing papers by A. Burchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Burchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Burchard. The network helps show where A. Burchard may publish in the future.

Co-authorship network of co-authors of A. Burchard

This figure shows the co-authorship network connecting the top 25 collaborators of A. Burchard. A scholar is included among the top collaborators of A. Burchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Burchard. A. Burchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Petersen, J., Karsten Wursthorn, Karl S. Oláh, et al.. (2017). Strong decrease of patients with advanced liver disease and more adherence problems to HCV therapy as DAA regimen enter third year of existence in Germany. Journal of Hepatology. 66(1). S522–S522. 1 indexed citations

Rillig, Andreas, Tina Lin, A. Burchard, et al.. (2014). Modified energy settings are mandatory to minimize oesophageal injury using the novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. EP Europace. 17(3). 396–402. 18 indexed citations

Metzner, Andreas, A. Burchard, Peter Wohlmuth, et al.. (2013). Increased Incidence of Esophageal Thermal Lesions Using the Second-Generation 28-mm Cryoballoon. Circulation Arrhythmia and Electrophysiology. 6(4). 769–775. 125 indexed citations

Metzner, Andreas, Erik Wißner, B. A. Schoonderwoerd, et al.. (2012). The influence of varying energy settings on efficacy and safety of endoscopic pulmonary vein isolation. Heart Rhythm. 9(9). 1380–1385. 34 indexed citations

Burchard, A., et al.. (2011). The Relationship between Blood Lactate and Survival following the Use of Adrenaline in the Treatment of Septic Shock. Anaesthesia and Intensive Care. 39(3). 449–455. 9 indexed citations

Tilz, Roland Richard, K. R. Julian Chun, Andreas Metzner, et al.. (2010). Unexpected High Incidence of Esophageal Injury Following Pulmonary Vein Isolation Using Robotic Navigation. Journal of Cardiovascular Electrophysiology. 21(8). 853–858. 67 indexed citations

Fürnkranz, Alexander, K. R. Julian Chun, Andreas Metzner, et al.. (2010). Esophageal Endoscopy Results After Pulmonary Vein Isolation Using the Single Big Cryoballoon Technique. Journal of Cardiovascular Electrophysiology. 21(8). 869–874. 51 indexed citations

Kraly, F. Scott, et al.. (1998). H2 histaminergic control of inhibition of eating induced by intragastric NaCl in rats. Physiology & Behavior. 65(1). 105–113. 9 indexed citations

Purrmann, J, Ulrich Mödder, S. Cleveland, et al.. (1993). Association of primary sclerosing cholangitis with inflammatory bowel diseases: a prospective study.. PubMed. 31 Suppl 5. 56–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact